P. Ferron

发表

Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity

B. Fromenty, Simon Bucher, K. Begriche, 2020, Cell Biology and Toxicology.

Sustainable pest management for cotton production. A review

Jean-Philippe Deguine, J. Deguine, P. Ferron, 2011, Agronomy for Sustainable Development.

Distribution of Listeria spp. in confectioners' pastries from western France: comparison of enrichment methods.

P. Ferron, J. Michard, 1993, International journal of food microbiology.

Aphid and whitefly management in cotton growing: review and challenges for the future

J. Deguine, P. Ferron, M. Vaissayre, 2004 .

Combined Effects of Lipophilic Phycotoxins (Okadaic Acid, Azapsiracid-1 and Yessotoxin) on Human Intestinal Cells Models

J. Beaulieu, V. Fessard, P. Ferron, 2016, Toxins.

Toxic Effects of Amanitins: Repurposing Toxicities toward New Therapeutics

P. Ferron, T. Gicquel, B. Le Daré, 2021, Toxins.

New insights into quetiapine metabolism using molecular networking

P. Allard, P. Ferron, I. Morel, 2020, Scientific Reports.

Crop Protection, Biological Control, Habitat Management and Integrated Farming

J. Deguine, P. Ferron, 2009 .

Crop protection, biological control, habitat management and integrated farming: A review

J. Deguine, P. Ferron, 2005 .

Biological Control of Insect Pests by Entomogenous Fungi

P. Ferron, 1978 .

Revision of the biodistribution of uranyl in serum: is fetuin-A the major protein target?

C. Vidaud, O. Pible, P. Ferron, 2013, Chemical research in toxicology.

Modulation of CYP3A4 activity alters the cytotoxicity of lipophilic phycotoxins in human hepatic HepaRG cells.

V. Fessard, G. de Sousa, R. Rahmani, 2016, Toxicology in vitro : an international journal published in association with BIBRA.

Comparative Analysis of the Cytotoxic Effects of Okadaic Acid-Group Toxins on Human Intestinal Cell Lines

V. Fessard, P. Ferron, K. Hogeveen, 2014, Marine drugs.

Physiological characteristics and virulence of auxotrophic and morphological mutants of Beauveria Brongniartii (sacc.) petch (= Beauveria tenella)

J. Fargues, S. Paris, P. Ferron, 1985, Mycopathologia.

Study of the virulence of some mutants of Beauveria brongniartii (= Beauveria tenella)

S. Paris, P. Ferron, Sophie Paris, 1979 .

Carbofuran self-poisoning: forensic and analytic investigations in twins and literature review

P. Ferron, I. Morel, T. Gicquel, 2022, International Journal of Legal Medicine.

Regulation of seasonal cycles in invertebrates.

B. Mauchamp, P. Ferron, J. Missonnier, 1990 .

Maitotoxin-4, a Novel MTX Analog Produced by Gambierdiscus excentricus

S. Fraga, R. Litaker, W. Holland, 2017, Marine drugs.

Influence of relative humidity on the development of fungal infection caused byBeauveria bassiana [Fungi Imperfecti, Moniliales] in imagines ofAcanthoscelides obtectus [Col.: Bruchidae]

P. Ferron, 1977, Entomophaga.

Susceptibility of Otiorhynchus sulcatus (Coleoptera: Curculionidae) Larvae to Metarhizium anisopliae and Metarhizium flavoviride (Deuteromycotina: Hyphomycetes) at Two Different Temperatures

M. Marchal, P. Ferron, G. Soares, 1983 .

Virulence of entomopathogenic Fungi (Fungi imperfecti) for the adults of Acanthoscelides obtectus (Coleoptera: Bruchidae)

P. Ferron, P. Robert, 1975 .

Depsipeptides from Metarhizium anisopliae

P. Ferron, B. Das, M. Païs, 1981 .

Pest control by the fungi Beauveria and Metarhizium

P. Ferron, P. Ferron, 1981 .

Susceptibility of Oryctes rhinoceros adults to Metarrhizium anisopliae

P. Ferron, P. Robert, A. Deotte, 1975 .

Molecular Networking for Drug Toxicities Studies: The Case of Hydroxychloroquine in COVID-19 Patients

K. Tarte, B. Fromenty, T. Hauet, 2021, International journal of molecular sciences.

Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?

B. Fromenty, B. Mégarbane, P. Ferron, 2020, Biochimie.

Arylcyclohexylamine Derivatives: Pharmacokinetic, Pharmacodynamic, Clinical and Forensic Aspects

P. Ferron, I. Morel, T. Gicquel, 2022, International journal of molecular sciences.

A selective medium for the isolation of Beauveria tenella and of Metarrhizium anisopliae.

P. Ferron, K. H. Veen, 1966, Journal of invertebrate pathology.

MODIFICATION OF THE DEVELOPMENT OF BEAUVERIA TENELLA MYCOSIS IN MELOLONTHA MELOLONTHA LARVAE, BY MEANS OF REDUCED DOSES OF ORGANOPHOSPHORUS INSECTICIDES

P. Ferron, 1971 .

Occurrence and pathogenicity ofBeauveria bassiana infesting larvalSitona discoideus [Col.: Curculionidae] in the Mediterranean region

M. Marchal, P. Ferron, J. Aeschlimann, 1985, Entomophaga.

Use of innovative, cross-disciplinary in vitro, in silico and in vivo approaches to characterize the metabolism of chloro-alpha-pyrrolidinovalerophenone (4-Cl-PVP)

P. Ferron, I. Morel, T. Gicquel, 2022, Archives of Toxicology.

In vivo and in vitro α-amanitin metabolism studies using molecular networking.

P. Ferron, I. Morel, T. Gicquel, 2021, Toxicology letters.

The Purinergic P2X7 Receptor-NLRP3 Inflammasome Pathway: A New Target in Alcoholic Liver Disease?

P. Ferron, T. Gicquel, B. Le Daré, 2021, International journal of molecular sciences.

Detection of Helicobacter pylori-like organisms in the stomach of some food-source animals using a monoclonal antibody.

R. Negrini, M. Londei, L. Cavazzini, 1992, The Italian journal of gastroenterology.

Metabolite elucidation of 2-Fluoro-Deschloroketamine (2F-DCK) using molecular networking across three complementary in vitro and in vivo models.

J. Gaulier, P. Ferron, I. Morel, 2021, Drug testing and analysis.

New psychoactive substance cocktail in an intensive care intoxication case elucidated by molecular networking

P. Ferron, I. Morel, T. Gicquel, 2021, Clinical toxicology.

Agroecology and ecological engineering for pest management. Cotton protection as a case study.

Jean-Philippe Deguine, Pierre Ferron, D. A. Russell, 2007 .

A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline

M. Dimanche-Boitrel, P. Ferron, I. Morel, 2022, Pharmaceutics.